(S052) Inverse Optimization for Correlating 4DCT Ventilation Imaging and Radiation Dose

Publication
Article
OncologyOncology Vol 29 No 4_Suppl_1
Volume 29
Issue 4_Suppl_1

A numerical method for computing a DIR transformation according to a target ventilation image was used to generate a ventilation image that correlates precisely with the dose distribution while maintaining high DIR spatial accuracy. Thus, by employing this approach, the focus of future CT ventilation studies that are designed to assess radiation dose response is reduced to assessing the physical feasibility of the DIR transformation that generates the ventilation image predicted by the dose-response model.

Edward Castillo, PhD, Richard Castillo, PhD, Thomas Guerrero, MD, PhD; Beaumont Health System; UT Medical Branch

PURPOSE: Four-dimensional computed tomography (4DCT) ventilation imaging is an emerging modality with utility in thoracic radiotherapy treatment planning. Though recent studies have demonstrated its potential for quantifying the functional response of lung tissue to irradiation, ventilation image analysis is challenging and difficult to reproduce because of issues such as spatial inaccuracies in the required deformable image registration (DIR), cine mode phase-binning artifacts, and variations in the patient’s breathing. In order to address these issues, we have developed a numerical method for computing 4DCT ventilation images that correlate perfectly with a given radiation dose distribution or dose-response model while maintaining high-spatial accuracy in the corresponding DIR solution.

METHODS: Ventilation images are defined by a DIR spatial transformation that maps the position of inhale lung voxels to their corresponding position at exhale (or vice versa). A voxel’s volume change under the transformation, described mathematically by the Jacobian matrix, is the intensity value of the ventilation image and quantifies the air exchanged. Given an initial DIR estimate and a target ventilation image, we define an optimization problem describing the spatial transformation closest to our initial estimate (according to the L2-norm), with Jacobian values equal to those in the target ventilation image.

RESULTS: The inhale/exhale phases of a treatment-planning 4DCT for a patient with non–small-cell lung cancer were registered using a previously reported DIR method. The spatial accuracy of the DIR solution, given as the average (standard deviation) millimeter error with respect to 417 expert-determined landmark points, was 1.03 (1.01) mm. The radiation dose distribution image was used to generate a target ventilation image using a linear dose-response model applied to the original ventilation image. Our numerical method was then applied to the initial DIR solution to produce a spatial transformation and corresponding ventilation image that matched the target ventilation image within 1e-2.The average millimeter error for the new transformation was 1.11 (1.10).

CONCLUSION: A numerical method for computing a DIR transformation according to a target ventilation image was used to generate a ventilation image that correlates precisely with the dose distribution while maintaining high DIR spatial accuracy. Thus, by employing this approach, the focus of future CT ventilation studies that are designed to assess radiation dose response is reduced to assessing the physical feasibility of the DIR transformation that generates the ventilation image predicted by the dose-response model.

Proceedings of the 97th Annual Meeting of the American Radium Society - americanradiumsociety.org

Articles in this issue

(P005) Ultrasensitive PSA Identifies Patients With Organ-Confined Prostate Cancer Requiring Postop Radiotherapy
(P001) Disparities in the Local Management of Breast Cancer in the United States According to Health Insurance Status
(P002) Predictors of CNS Disease in Metastatic Melanoma: Desmoplastic Subtype Associated With Higher Risk
(P003) Identification of Somatic Mutations Using Fine Needle Aspiration: Correlation With Clinical Outcomes in Patients With Locally Advanced Pancreatic Cancer
(P004) A Retrospective Study to Assess Disparities in the Utilization of Intensity-Modulated Radiotherapy (IMRT) and Proton Therapy (PT) in the Treatment of Prostate Cancer (PCa)
(S001) Tumor Control and Toxicity Outcomes for Head and Neck Cancer Patients Re-Treated With Intensity-Modulated Radiation Therapy (IMRT)-A Fifteen-Year Experience
(S003) Weekly IGRT Volumetric Response Analysis as a Predictive Tool for Locoregional Control in Head and Neck Cancer Radiotherapy 
(S004) Combination of Radiotherapy and Cetuximab for Aggressive, High-Risk Cutaneous Squamous Cell Cancer of the Head and Neck: A Propensity Score Analysis
(S005) Radiotherapy for Carcinoma of the Hypopharynx Over Five Decades: Experience at a Single Institution
(S002) Prognostic Value of Intraradiation Treatment FDG-PET Parameters in Locally Advanced Oropharyngeal Cancer
(P006) The Role of Sequential Imaging in Cervical Cancer Management
(P008) Pretreatment FDG Uptake of Nontarget Lung Tissue Correlates With Symptomatic Pneumonitis Following Stereotactic Ablative Radiotherapy (SABR)
(P009) Monte Carlo Dosimetry Evaluation of Lung Stereotactic Body Radiosurgery
(P010) Stereotactic Body Radiotherapy for Treatment of Adrenal Gland Metastasis: Toxicity, Outcomes, and Patterns of Failure
(P011) Stereotactic Radiosurgery and BRAF Inhibitor Therapy for Melanoma Brain Metastases Is Associated With Increased Risk for Radiation Necrosis
Recent Videos
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
Although accuracy remains a focus in whole-body MRI testing in patients with Li-Fraumeni syndrome, comfortable testing experiences may ease anxiety.
Subsequent testing among patients in a prospective study may affirm the ability of cfDNA sequencing to detect cancers in those with Li-Fraumeni syndrome.
cfDNA sequencing may allow for more accessible, frequent, and sensitive testing compared with standard surveillance in Li-Fraumeni syndrome.
STX-478 showed efficacy in patients with advanced solid tumors regardless of whether they had kinase domain or helical PI3K mutations.
STX-478 may avoid adverse effects associated with prior PI3K inhibitors that lack selectivity for the mutated protein vs the wild-type protein.
Phase 1 data may show the possibility of rationally designing agents that can preferentially target PI3K mutations in solid tumors.
Funding a clinical trial to further assess liquid biopsy in patients with Li-Fraumeni syndrome may help with detecting cancers early across the board.
Michael J. Hall, MD, MS, FASCO, discusses the need to reduce barriers to care for those with Li-Fraumeni syndrome, including those who live in rural areas.
Related Content